Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EndoSure
Sparks Glencoe, Maryland, United Statesendosure.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The EndoSure Test is a non-invasive, AI-driven device for diagnosing endometriosis with over 99% accuracy, delivering results in 30 minutes; clinical validation data claim detection for all four stages and supports post-treatment monitoring.
- Therapeutic areas
- Women's Health
- Modalities
- DeviceAI-driven diagnostics
- Industry
- Digital Health Medical Devices
02
Partnerships
Distribution agreements for UK, Brazil, Canada, Gulf States, Israel
Beyond the preview
Go deeper on EndoSure.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EndoSure.